Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 249–249 | Cite as

Imatinib

Bilateral pleural effusion and chronic kidney disease: case report
Case report
  • 22 Downloads

Reference

  1. Malkan UY, et al. Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia. Open Medicine 14: 22-24, No. 1, 2019. Available from: URL: http://doi.org/10.1515/med-2019-0004 - Turkey

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations